Hand-Foot Syndrome - 26 Studies Found Completed : Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED) : Ovarian Neoplasms : 2008-08-26 : Drug: Caelyx (Pegylated Lyposomal Doxorubicin) Pegylated Lyposomal Doxorubicin, 50 mg/m2 every 4 weeks f Completed : Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer : Breast Cancer Drug/Agent Toxicity by Tissue/Organ Unspecif : 2006-02-23 : Dietary Supplement: pyridoxine hydrochloride Completed : A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) : Ovarian Neoplasms Breast Neoplasms Paresthesia : 2008-09-03 Recruiting : Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment : Metastatic Renal Cell Carcinoma : 2016-05-17 Completed : DOXIL for Consolidation Therapy in Ovarian Cancer. : Ovarian Neoplasm : 2005-11-01 : Drug: liposomal doxorubicin Doxil at 50mg/m2 infused over one hour every 3 or 4 weeks for 3-6 cycles RECRUITING : Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial : Hand-Foot Syndrome : 2024-05-13 : This group receives a 30-minute nursing consultation on the standard treatment according to the guideline "Supportive Therapy" for hand-foot <<< Previous